Lewis Acid‐Driven Weak Electrostatic Interaction of Polybenzimidazole‐Based Membrane for Alkaline Zinc‐Iron Redox Flow Batteries
Advanced Materials · 2025-11 · 37 (45)
DOI: 10.1002/adma.202510023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.09.2025. Verfasst von Xinru Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong, 999077, P. R. China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Alkaline zinc‐iron flow batteries (AZIFBs) are one of the promising aqueous redox chemistries for large‐scale energy storage due to their intrinsic safety and low cost. However, the energy efficiency (EE) and power density of batteries with low‐cost polybenzimidazole (PBI) membranes are still limited due to the relatively poor ionic conductivity of PBI in an alkaline medium. Here, this study proposes a novel chemical approach for regulating the chemical environment of the PBI membrane. Specifically, AlF 3 , as a representative Lewis acid, is employed to reduce the electron cloud density of the benzimidazole (BI) ring, weaken the electrostatic interactions between the BI ring and charge‐balancing ions, and thereby accelerate the diffusion of charge‐balancing ions. Characterizations on the AlF 3 ‐PBI membranes reveal that the enhanced ion transport can be ascribed to decreased electron cloud density of BI rings and reduced ion diffusion resistance. Charge density difference analysis further illustrates the electron‐withdrawing feature of AlF 3 as a Lewis acid. AZIFBs using AlF 3 ‐PBI membrane demonstrate excellent rate capability from 40 to 240 mA cm −2 with EE of more than 80%, and an outstanding power density of nearly 1000 mW cm −2 . The battery also performs decent cycle stability of 500 cycles at a high current density of 140 mA cm −2 with EE over 80%, resulting from the robust stability of the AlF 3 ‐PBI membrane and the reliability of the strategy. This study highlights the potential of Lewis acid‐based chemical regulation to optimize PBI‐based membranes, offering a new perspective for enhancing the performance of AZIFBs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Materials Science and Engineering, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong, 999077, P. R. China.
- Hong Kong Center for Cerebro-Cardiovascular Health Engineering (COCHE), NT, HKSAR, Shatin, 999077, P. R. China.
- Center for Advanced Nuclear Safety and Sustainable Development, City University of Hong Kong, Kowloon, Hong Kong, 999077, P. R. China.
- Hong Kong Institute for Advanced Study, City University of Hong Kong, Kowloon, Hong Kong, 999077, P. R. China.
- Hong Kong Institute for Clean Energy, City University of Hong Kong, Kowloon, Hong Kong, 999077, Hong Kong.
- Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong, 999077, China.
ORCID-Profile: Chunyi Zhi
Zitieren
APA
Yang, X., Wei, Z., Hu, H., Hong, H., Wang, Y., Zhu, J., Li, P., Wang, T., Fan, J., & Zhi, C. (2025). Lewis Acid‐Driven Weak Electrostatic Interaction of Polybenzimidazole‐Based Membrane for Alkaline Zinc‐Iron Redox Flow Batteries. Advanced Materials, 37(45). https://doi.org/10.1002/adma.202510023
Vancouver
Yang X, Wei Z, Hu H, Hong H, Wang Y, Zhu J, et al. Lewis Acid‐Driven Weak Electrostatic Interaction of Polybenzimidazole‐Based Membrane for Alkaline Zinc‐Iron Redox Flow Batteries. Advanced Materials. 2025;37(45). doi:10.1002/adma.202510023
BibTeX
@article{Yang2025,
author = {Yang, Xinru and Wei, Zhiquan and Hu, Honglu and Hong, Hu and Wang, Yiqiao and Zhu, Jiaxiong and Li, Pei and Wang, Tairan and Fan, Jun and Zhi, Chunyi},
title = {Lewis Acid‐Driven Weak Electrostatic Interaction of Polybenzimidazole‐Based Membrane for Alkaline Zinc‐Iron Redox Flow Batteries},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {45},
doi = {10.1002/adma.202510023}
}
EUVIMED